Profil
Jason S.
Ehrlich is the founder of Ollin Biosciences, Inc., founded in 2023, where the title held is Chief Executive Officer & Director.
Former jobs include Global Head-Clinical Ophthalmology at Genentech, Inc. from 2008 to 2018, and Chief Medical & Development Officer at Kodiak Sciences, Inc. from 2018 to 2023.
Education history includes undergraduate studies at Princeton University and a doctorate from Stanford University School of Medicine.
Aktiva positioner av Jason Ehrlich
| Företag | Position | Start |
|---|
Tidigare kända positioner av Jason Ehrlich
| Företag | Position | Slut |
|---|---|---|
| KODIAK SCIENCES INC. | Teknisk/Vetenskaplig/F&U Direktör | 2023-08-25 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Företagsledare/Principal | 2018-01-01 |
Jason Ehrlichs utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Princeton University
Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University School of Medicine
Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kodiak Sciences, Inc.
Kodiak Sciences, Inc. BiotechnologyHealth Technology Develops novel therapies for the treatment of retinal disease | Health Technology |
















